Ian F. Smith, EVP, CFO & COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 98,553 shares at $124.00 ($12.2M) on 2017-06-01, disclosed to the SEC on 2017-06-05.
Scheduled sale ($12.2M) by EVP, CFO & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |